Preferential expression of AChR epsilon-subunit in thymomas from patients with myasthenia gravis.

Preferential expression of AChR epsilon-subunit in thymomas from patients with myasthenia gravis.

The role of antigen expression by thymomas in myasthenia gravis (MG) is not clear. Previous reports of acetylcholine receptor (AChR) mRNA expression by the highly sensitive reverse transcription-polymerase chain reactions (RT-PCR) produced varying results. To try to clarify this issue, we first used...

وصف كامل

التفاصيل البيبلوغرافية
المؤلفون الرئيسيون:	Maclennan, C, Vincent, A, Marx, A, Willcox, N, Gilhus, N, Newsom-Davis, J, Beeson, D
التنسيق:	Journal article
اللغة:	English
منشور في:	2008

مواد مشابهة

Myasthenia gravis in a woman with congenital AChR deficiency due to epsilon-subunit mutations.
حسب: Croxen, R, وآخرون
منشور في: (2002)

Antibodies to AChRs in seronegative myasthenia gravis
حسب: Leite, M, وآخرون
منشور في: (2006)

Effect of sera from AChR-antibody negative myasthenia gravis patients on AChR and MuSK in cell cultures.
حسب: Farrugia, M, وآخرون
منشور في: (2007)

Congenital myasthenic syndrome patients due to AChR epsilon subunit mutations
حسب: Bonifati, D, وآخرون
منشور في: (2004)

Autoantibodies in thymoma-associated myasthenia gravis with myositis or neuromyotonia.
حسب: Mygland, A, وآخرون
منشور في: (2000)

End-plate gamma- and epsilon-subunit mRNA levels in AChR deficiency syndrome due to epsilon-subunit null mutations.
حسب: Croxen, R, وآخرون
منشور في: (2001)

Splice-site mutations in the achr epsilon subunit gene associated with congenital myasthenic syndrome
حسب: Croxen, R, وآخرون
منشور في: (2000)

Thymoma and paraneoplastic myasthenia gravis.
حسب: Marx, A, وآخرون
منشور في: (2010)

AChR deficiency due to epsilon-subunit mutations: two common mutations in the Netherlands.
حسب: Faber, C, وآخرون
منشور في: (2009)

Correlation between polymorphisms in the AChR gamma and delta subunit promoters and clinical phenotype in AChR deficiency patients
حسب: Bonifati, D, وآخرون
منشور في: (2004)

Differential Cytokine Changes in Patients with Myasthenia Gravis with Antibodies against AChR and MuSK.
حسب: Vuslat Yilmaz, وآخرون
منشور في: (2015-01-01)

Compromised fidelity of B-cell tolerance checkpoints in AChR and MuSK myasthenia gravis
حسب: Lee, J, وآخرون
منشور في: (2016)

Nomogram for short-term outcome assessment in AChR subtype generalized myasthenia gravis
حسب: Rui Zhao, وآخرون
منشور في: (2021-06-01)

Mature, long-lived CD4+ and CD8+ T cells are generated by the thymoma in myasthenia gravis.
حسب: Buckley, C, وآخرون
منشور في: (2001)

Characterization of an anti-fetal AChR monoclonal antibody isolated from a myasthenia gravis patient
حسب: Saxena, A, وآخرون
منشور في: (2017)

Lack of association between acetylcholine receptor epsilon polymorphisms and early-onset myasthenia gravis.
حسب: Bonifati, D, وآخرون
منشور في: (2004)

A Stable Cell Line Expressing Clustered AChR: A Novel Cell-Based Assay for Anti-AChR Antibody Detection in Myasthenia Gravis
حسب: Yu Cai, وآخرون
منشور في: (2021-07-01)

Clinical comparison of anti-MuSK- vs anti-AChR-positive and seronegative myasthenia gravis.
حسب: Deymeer, F, وآخرون
منشور في: (2007)

The clinical outcome in AChR-positive generalized myasthenia gravis: A retrospective observational study
حسب: Pawan T Ojha, وآخرون
منشور في: (2023-01-01)

Direct proof of the in vivo pathogenic role of the AChR autoantibodies from myasthenia gravis patients.
حسب: Gregory Kordas, وآخرون
منشور في: (2014-01-01)

The association of PTPN22 R620W polymorphism is stronger with late-onset AChR-myasthenia gravis in Turkey.
حسب: Gizem A Kaya, وآخرون
منشور في: (2014-01-01)

Impact of COVID-19 in AChR Myasthenia Gravis and the Safety of Vaccines: Data from an Italian Cohort
حسب: Antonino Lupica, وآخرون
منشور في: (2022-04-01)

Correction: Direct Proof of the In Vivo Pathogenic Role of the AChR Autoantibodies from Myasthenia Gravis Patients.
حسب: PLOS ONE Staff
منشور في: (2015-01-01)

Correction: direct proof of the in vivo pathogenic role of the AChR autoantibodies from myasthenia gravis patients.
حسب: PLOS ONE Staff
منشور في: (2015-01-01)

Oral Microbiota Profile in a Group of Anti-AChR Antibody–Positive Myasthenia Gravis Patients
حسب: Chao Huang, وآخرون
منشور في: (2022-07-01)

A cysteine residue close to the C-terminus of the E subunit is essential for surface acetylcholine receptor (AChR) expression: Implications for AChR deficiency syndrome
حسب: Ealing, J, وآخرون
منشور في: (2002)

Selective silencing of pathogenic a subunit AChR mutant in dominant disorders
حسب: Abdelgany, A, وآخرون
منشور في: (2004)

Autoantibody of NRIP, a novel AChR‐interacting protein, plays a detrimental role in myasthenia gravis
حسب: Li‐Kai Tsai, وآخرون
منشور في: (2021-06-01)

Clinical outcomes in AchR antibody-positive myasthenia gravis: Where does rituximab stand in the current times?
حسب: Megha Chetan Dhamne
منشور في: (2023-01-01)

Mutations in congenital myasthenic syndromes reveal an epsilon subunit C-terminal cysteine, C470, crucial for maturation and surface expression of adult AChR.
حسب: Ealing, J, وآخرون
منشور في: (2002)

Neuromyotonia and myasthenia gravis without thymoma.
حسب: Van Parijs, V, وآخرون
منشور في: (2002)

Slow‐channel myasthenia due to novel mutation in M2 domain of AChR delta subunit
حسب: Xin‐Ming Shen, وآخرون
منشور في: (2019-10-01)

Ocular myasthenia gravis and thymoma
حسب: Victor Alegre-Ituarte, وآخرون
منشور في: (2022-09-01)

AChR phosphorylation and indirect inhibition of AChR function in seronegative MG.
حسب: Plested, C, وآخرون
منشور في: (2002)

Consensus recommendation for the treatment of generalised Myasthenia Gravis with anti-acetylcholine receptor antibodies (gMG AChR+) in Spain
حسب: Elena Cortés-Vicente, وآخرون
منشور في: (2025-01-01)

Short-term and long-term prognoses in AChR-Ab positive very-late-onset myasthenia gravis patients
حسب: Nairong Xie, وآخرون
منشور في: (2025-01-01)

Mutation in the AChR ion channel gate underlies a fast channel congenital myasthenic syndrome.
حسب: Webster, R, وآخرون
منشور في: (2004)

Discovery of functionally distinct anti-C7 monoclonal antibodies and stratification of anti-nicotinic AChR positive Myasthenia Gravis patients
حسب: Eleonora Lekova, وآخرون
منشور في: (2022-09-01)

Clinical Characteristics and Prognosis of Anti-AChR Positive Myasthenia Gravis Combined With Anti-LRP4 or Anti-Titin Antibody
حسب: Yuping Chen, وآخرون
منشور في: (2022-05-01)

Structural abnormalities of the AChR caused by mutations underlying congenital myasthenic syndromes.
حسب: Beeson, D, وآخرون
منشور في: (2003)